64Z Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - KeyMed Biosciences Inc

Watchlist Manager

Watchlist

Price: 9.55 EUR 5.52% Market Closed

Market Cap: €2.6B

K	KeyMed Biosciences Inc F:64Z	CN
A	Arch Resources Inc SWB:ACCA	US
X	Xylem Inc F:XY6	US

Profitability Summary

KeyMed Biosciences Inc's profitability score is 20/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

88%

Strong 3Y Average Gross Margin

89%

Declining Gross Margin

95% > 88%

Negative Operating Margin

-74%

Negative 3Y Average Operating Margin

-243%

Operating Margin is Increasing

-119% > -74%

Negative Net Margin

-73%

Negative 3Y Average Net Margin

-219%

Net Margin is Increasing

-81% > -73%

Negative Free Cash Flow Margin

-120%

Negative 3Y Average Free Cash Flow Margin

-322%

Free Cash Flow Margin is Increasing

-180% > -120%

Negative ROE

-20%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-43%

ROIC is Increasing

-45% > -28%

View All

Hide

Collapse

20 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.